FDA and NCATS launch CURE ID app for healthcare professionals

6th December 2019 (Last Updated December 6th, 2019 14:53)

The US Food and Drug Administration (FDA) and the National Institutes of Health’s (NIH) National Center for Advancing Translational Sciences (NCATS) have launched a new app called CURE ID for health care professionals.

The US Food and Drug Administration (FDA) and the National Institutes of Health’s (NIH) National Center for Advancing Translational Sciences (NCATS) have launched a new app called CURE ID for health care professionals.

They will be able to log case data of patients using the app when treating difficult infections.

CURE ID is an online data repository that will allow clinicians to report instances where existing FDA-approved drugs are used to successfully treat infections through a mobile platform.

It captures clinical data when drugs are used for new diseases indications, in new populations, or at instances when they are used in new doses or in new combinations.

The platform enables the crowdsourcing of medical information from healthcare providers to guide potentially life-saving treatments and facilitate the development of new drugs for rare diseases.

This crowdsourcing approach aligns with a push for accelerating real-world data generation and analysis within the healthcare industry.

FDA Principal Deputy Commissioner Amy Abernethy said: “The CURE ID application focuses on drugs for infectious diseases lacking adequate treatments, including neglected tropical diseases, emerging infectious threats and infections caused by antimicrobial-resistant organisms.

“When healthcare professionals directly input their clinical cases into the app, CURE ID allows these real-world experiences to be organised and analysed much faster, making it easier to spot promising new uses for existing drugs.”

With CURE ID, caregivers complete a case report form with regard to their experience using an approved product for an unapproved use.

Healthcare professionals can also browse from a collection of cases that have already been documented and can also view relevant clinical trials and those open to enrolment at clinicaltrials.gov.

The FDA said that it intends to reach out to healthcare providers in various therapy classes, such as infectious and tropical diseases, encouraging them to use the app.

According to the agency, CURE ID includes data on 325 infectious diseases and syndromes consisting of nearly 1,500 case reports and over 18,000 published clinical trials.